Sunday, Jun 15th
Last update07:14:22 AM GMT
Eli Lilly & Co. trained its sales force to downplay risks for Zyprexa and encourage doctors to prescribe the drug beyond approved uses for schizophrenia and bipolar disorder, according to court documents.
Lilly's research showed some patients on Zyprexa gained as much as 80 pounds and that the incidence of high blood sugar at diabetes levels was 3.5 times higher than for placebos, according to documents filed in a lawsuit brought by the state of Alaska.
 A unanimous Court on June 12 made it easier for families to use the Americans with Disabilities... |
 Health Secretary Robert F. Kennedy Jr. has fired all 17 members of a committee that advises... | ||
US lawmakers on both sides of the aisle are raising concerns and seeking investigations in the... |
 A public health alert has been issued for organic ground beef products that reportedly could be... |
